EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues
- 335 Downloads
These guidelines summarise the views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The purpose of the guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of PET or SPECT imaging of brain tumours using radiolabelled amino acid analogues. The aim is to help in achieving a high quality of tumour imaging using radiolabelled amino acids, which will allow the diagnostic impact of this technique in neuro-oncological practice to be increased.
The present document has been inspired by a review of the literature and the individual experience of experts in European countries. The guidelines are intended to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.
Background information and definitions
Increased amino acid transport in brain tumour cells results from overexpression of the...
KeywordsTumour Uptake Normal Brain Tissue Focal Cortical Dysplasia Amino Acid Uptake Label Amino Acid
The members of the ENC acknowledge the assistance provided by the following persons (in alphabetical order) in reading the guidelines and providing constructive comments based on their expertise: R.G. Blasberg, USA, E. Bombardieri, Italy, K. Ericson, Sweden, S. Goldman, Belgium, and K. Herholz, T. Kuwert, K.J. Langen and W. Weber, Germany.
- 2.Langen KJ, Pauleit D, Coenen HH. 3-[123I]Iodo-α-methyl-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002;29:631Google Scholar